An expert, independent second opinion on more than 1,800 prescription drugs, over-the-counter medications, and supplements

[print friendlyprint friendly]

Recent postings to
Worst Pills, Best Pills Newsletter Articles

  View the entire January 2015 issue in PDF format

  • Gambling, Hypersexuality And Compulsive Shopping: Drugs That Make You Lose Control
    (January 2015)
    Find out which drugs used to treat Parkinson’s disease, restless legs syndrome and the hormone disorder hyperprolactinemia can cause uncontrollable impulsive behaviors, including compulsive gambling and shopping, hypersexuality, and binge eating.
  • Republican Takeover of Senate Imperils Drug Safety
    (January 2015)
    Given the changes in the makeup of the U.S. Senate following the November elections, Congress is likely to pass new legislation that will weaken the FDA’s rules for ensuring that drugs are safe and effective. Read Dr. Michael Carome’s column to find out why.
  • New Evidence of Flaws in Approach to PRADAXA Dosing
    (January 2015)
    One of the supposed major advantages of the anticoagulant dabigatran (PRADAXA) touted by its manufacturer is that patients can take a fixed dose of the drug and do not need to undergo periodic monitoring with blood tests to adjust the dose. This article presents new research data that casts doubt on the safety of this fixed-dose approach.
  • News Briefs for January 2015
    (January 2015)
    In a new feature that will appear periodically in issues of Worst Pills, Best Pills News, we highlight recent important news items related to drug safety. In this month’s news briefs, we report on (a) a recent FDA warning about over-the-counter drugs that can make you drowsy; (b) action taken by the Federal Trade Commission against a company for false advertising of green coffee beans as a miracle weight loss remedy; and (c) the American Academy of Neurology’s position statement cautioning against the use of narcotic drugs for treatment of chronic noncancer pain.
  • CRESTOR Lacks Any Health Benefit for High Cholesterol; Likely to Increase Risk of Diabetes
    (January 2015)
    Since 2003, Public Citizen’s Health Research Group has advised readers not to use rosuvastatin (CRESTOR). Learn about the newest research indicating that rosuvastatin is more dangerous than other available statin drugs.
  • Sleep Disorder Treatment for Blind Persons May Be Marketed More Widely
    (January 2015)
    The FDA recently approved a drug for treatment of a sleep disorder that occurs primarily in people who are totally blind. Find out the name of this new drug and learn about concerns that the company may seek to market the drug to a much wider population of patients who are not blind.

  View the entire December 2014 issue in PDF format

  • Pregabalin (LYRICA): OK for Certain Seizures, but Not Pain
    (December 2014)
    LYRICA is heavily promoted for treatment of chronic pain due to fibromyalgia and other conditions. Learn why Public Citizen’s Health Research Group advises against using the drug to treat these painful conditions.
  • Sunshine Law Exposes Vast Industry Payments to Physicians
    (December 2014)
    In his editor’s column, Dr. Michael Carome discusses the implications of data recently released by the federal government that reveals the staggering amount of money drug and medical device companies are paying doctors and teaching hospitals.
  • Restless Legs Syndrome: Overdiagnosed and Overtreated
    (December 2014)
    In this review of restless legs syndrome (RLS), we discuss the limitations of the available drug treatments for the disorder and the nondrug approaches that are the safest options for people with mild to moderate RLS symptoms.
  • Albiglutide (TANZEUM): Another Me-Too Drug for Type 2 Diabetes
    (December 2014)
    Read about the dangers posed by albiglutide, yet another new diabetes drug designated as Do Not Use by Public Citizen’s Health Research Group because it offers no unique benefits but does pose unique risks.
  • Adding NSAIDS or Aspirin to Anticoagulants Increases Bleeding Danger
    (December 2014)
    If you are one of the millions of patients in the U.S. who take blood thinners on a long-term basis to prevent potentially harmful clots in the heart, veins or arteries, read this article to learn why you should avoid taking NSAIDS or aspirin unless absolutely necessary.

   View back issues January 2004 - present

Additional Information from Public Citizen
Copyright © 2015 Public Citizen's Health Research Group. All rights reserved.